1. Benzimidazole‐based structure optimization to discover novel anti‐gastric cancer agents targeting ROS/MAPK pathway.
- Author
-
Jia, Gang, Wang, Yuanying, Wang, Jikuan, Yu, Bingxin, Zhao, Haiyang, Zhao, Ze, Zhao, Wenming, Gao, Ya, Wang, Bo, and Song, Zhiyu
- Subjects
BENZIMIDAZOLES ,HYDROCORTISONE ,MITOGEN-activated protein kinases ,REACTIVE oxygen species ,LEAD compounds ,STRUCTURAL optimization - Abstract
Given the malignancy of gastric cancer, developing highly effective and low‐toxic targeted drugs is essential to prolong patient survival and improve patient outcomes. In this study, we conducted structural optimizations based on the benzimidazole scaffold. Notably, compound 8 f presented the most potent antiproliferative activity in MGC803 cells and induced cell cycle arrest at the G0/G1 phase. Further mechanistic studies demonstrated that compound 8 f caused the apoptosis of MGC803 cells by elevating intracellular reactive oxygen species (ROS) levels and activating the mitogen‐activated protein kinase (MAPK) signaling pathway, accompanied by corresponding markers change. In vivo investigations additionally validated the inhibitory effect of compound 8 f on tumor growth in xenograft models bearing MGC803 cells without obvious toxicity. Our studies suggest that compound 8 f holds promise as a potential and safe lead compound for developing anti‐gastric cancer agents. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF